Methotrexate Injection IP Methotrek 50

Name: Methotrexate Injection IP Methotrek 50
Brand: PHP Lifesciences LLP
Price: 50.40 INR
Availability: InStock

Price 50.40 INR/ Vial

Get a Price/Quote

MOQ : 10 Vials

Methotrexate Injection IP Methotrek 50 Specification

Indication
Used in the treatment of certain types of cancer, severe psoriasis and rheumatoid arthritis

Dosage Form
Injection

Salt Composition
Methotrexate 50 mg/2ml

Feature
Single-dose vial, sterile, pyrogen-free

Application
Antineoplastic and immunosuppressant therapy

Ph Level
4.5-8.0

Physical Color/Texture
Clear yellow solution

Fermentation Smell
Odorless

Storage Instructions
Store below 25C. Protect from light. Do not freeze.

Shelf Life
24 months

Packaging
2 ml vial

Controlled Substance
No

Prescription
Prescription only medicine

Warning
Cytotoxic agent - handle with care

Reconstitution
Not required (ready-to-use solution)

Administration Route
Intramuscular, intravenous, intra-arterial, or intrathecal injection

ATC Classification
L01BA01

Marketed By
Troikaa Pharmaceuticals Ltd.

Preservation
No added preservatives

Container Material
Glass vial, rubber stopper, aluminum seal

Methotrexate Injection IP Methotrek 50 Trade Information

Minimum Order Quantity
10 Vials

Supply Ability
1000 Vials Per Month

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Methotrexate Injection IP Methotrek 50

Experience the latest in antineoplastic and immunosuppressant therapy with Methotrexate Injection IP Methotrek 50. This fresh, gilt-edged formulation presents a ready-to-use, clear yellow solution containing 50 mg of Methotrexate in a 2 ml vial. Packaged with a glass vial, rubber stopper, and aluminum seal, it ensures a grand standard of sterility with no added preservatives. Designed for best use via multiple administration routes-intramuscular, intravenous, intra-arterial, or intrathecal-this prescription-only injection grants broad access for treating various cancers, severe psoriasis, and rheumatoid arthritis. Exclusively from Troikaa Pharmaceuticals Ltd., this premium product is indispensable for healthcare providers, dealers, and distributors.

The Grand Advantage: Versatile Application and Competitive Edge

Methotrexate Injection IP Methotrek 50 stands out with its wide application in oncology and autoimmune disorders. Its principal advantage lies in its ready-to-use, single-dose design with no reconstitution necessary, ensuring efficient treatment delivery. This injection is ideal for hospitals, clinics, and specialty oncology centers, offering competitive benefits like premium sterility, convenience, and a broad therapeutic spectrum. With its long shelf life and reliable packaging, it delivers top-tier value to professionals seeking gilt-edged therapies.

Order Exchange, Sale Price, and Rapid Delivery for Methotrek 50

A sample of Methotrexate Injection IP Methotrek 50 can be provided upon request to facilitate confident purchasing decisions. Dealers, exporters, and suppliers will find favorable payment terms available to simplify exchange and transaction processes. With competitive sale prices and prompt order completion, this product ensures swift delivery and minimal waiting time. Secure transactions and timely shipping across India make access seamless for wholesalers and traders seeking grand pharmaceutical solutions.

FAQ's of Methotrexate Injection IP Methotrek 50:

Q: How should Methotrexate Injection IP Methotrek 50 be administered?

A: Methotrexate Injection IP Methotrek 50 can be administered intramuscularly, intravenously, intra-arterially, or intrathecally. It should be used under the direct supervision of healthcare professionals according to the prescribed medical protocol.

Q: What conditions does Methotrexate Injection IP Methotrek 50 treat?

A: Methotrek 50 is used for the treatment of certain cancers, severe psoriasis, and rheumatoid arthritis. Its antineoplastic and immunosuppressant properties make it effective for these indications.

Q: Where should Methotrexate Injection IP Methotrek 50 be stored for optimal preservation?

A: Store the vial below 25C, protect it from light, and avoid freezing. Proper storage ensures maximum potency throughout its 24-month shelf life.

Q: What are the benefits of using Methotrek 50's ready-to-use formulation?

A: The ready-to-use solution eliminates the need for reconstitution, reducing preparation time and minimizing the risk of contamination. This offers a significant advantage in urgent or high-volume medical settings.

Q: When can samples of Methotrexate Injection IP Methotrek 50 be requested for evaluation?

A: Samples are available on request to distributors and medical institutions prior to bulk purchasing, aiding in product selection and quality assurance before finalizing orders.

Q: What should be considered when handling Methotrexate Injection IP Methotrek 50?

A: As a cytotoxic agent, Methotrek 50 must be handled with care, utilizing appropriate protective equipment and following established guidelines for handling and disposal to ensure safety.

Tell us about your requirement